1. The MHC sequencing consortium. Complete sequence and gene map of a human major histocompatibility complex. The MHC sequencing consortium. Nature 1999; 401 (6756): 921-3.
2. Belov K., et al. Reconstructing an ancestral mammalian immune supercomplex from a marsupial major histocompatibility complex. PLoS Biol 2006; 4(3): e46.
3. Abbas AK. Antigen presentation by B lymphocytes: mechanisms and functional significance. Semin Immunol 1989; 1(1): 5-12.
4. Braciale TJ, et al. Antigen presentation pathways to class I and class II MHC-restricted T lymphocytes. Immunol Rev 1987; 98: 95-114.
5. Vyas JM, Van der Veen AG, Ploegh HL. The known unknowns of antigen processing and presentation. Nat Rev Immunol 2008; 8(8): 607-18.
6. Cresswell P, et al. Mechanisms of MHC class I-restricted antigen processing and cross-presentation. Immunol Rev 2005; 207: 145-57.
7. Rock KL, Shen L. Cross-presentation: underlying mechanisms and role in immune surveillance. Immunol Rev 2005; 207: 166-83.
8. Gorer P, Lyman S, Snell G. Studies on the genetic and antigenic basis of tumour transplantation. Linkage between a histocompatibility gene and “fused” in mice. Proceedings of the Royal Society of London - Series B. Biological Sciences 1948; 135: 6.
9. Snell G. Methods for the study of histocompatibility genes. J Genet 1948; 49: 21.
10. Snell G. A fifth allele at the histocompatibility-2 locus of the mouse as determined by tumor transplantation. J Natl Cancer Inst 1951; 11: 6.
11. Zinkernagel RM, Doherty PC. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature 1974; 248(450): 701-2.
12. Farrell C, Honeyman M, Hoadley C. An analysis of the effect of HLA-DP in the mixed lymphocyte reaction. J Immunogenet 1988; 15(5-6): 243-50.
13. Khalil-Daher I, et al. Human leukocyte antigen-G: immunotolerant major histocompatibility complex molecule in transplantation. World J Surg 2000; 24(7): 819-22.
14. Solheim BG, et al. Influence of HLA-A, -B, -C, and -D matching on the outcome of clinical kidney transplantation. Transplant Proc 1977; 9(1): 475-8.
15. Eng HS, Leffell MS. Histocompatibility testing after fifty years of transplantation. J Immunol Methods 2011; 369(1-2): 1-21.
16. Van Rood JJ. Tissue typing and organ transplantation. Lancet 1969; 1(7606): 1142-6.
17. Ting A, Terasaki PI. Lymphocyte-dependent antibody cross-matching for transplant patients. Lancet 1975; 1(7902): 304-6.
18. Brando B, Sommaruga E. Flow cytometry cross-match. Eur J Histochem 1996; 40 Suppl 1: 53-62.
19. Bidwell JL, Bidwell EA, Bradley BA. HLA class II genes: typing by DNA analysis. Baillieres Clin Haematol 1990; 3(2): 355-84.
20. Arora M, et al. HLA-identical sibling compared with 8/8 matched and mismatched unrelated donor bone marrow transplant for chronic phase chronic myeloid leukemia. J Clin Oncol 2009; 27(10): 1644-52.
21. Yakoub-Agha I, et al. Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the French Society of Bone Marrow Transplantation and Cell Therapy. J Clin Oncol 2006; 24(36): 5695-702.
22. Malkki M, et al. Mapping MHC-resident transplantation determinants. Biol Blood Marrow Transplant 2007; 13(8): 986-95.
23. The International HapMap Consortium. A haplotype map of the human genome. Nature 2005; 437(7063): 1299-320.
24. Miretti MM, et al. A high-resolution linkage-disequilibrium map of the human major histocompatibility complex and first generation of tag single-nucleotide polymorphisms. Am J Hum Genet 2005; 76(4): 634-46.
25. Horton R, et al. Variation analysis and gene annotation of eight MHC haplotypes: the MHC Haplotype Project. Immunogenetics 2008; 60(1): 1-18.
26. Petersdorf EW, et al. MHC haplotype matching for unrelated hematopoietic cell transplantation. PLoS Med 2007; 4(1): e8.
27. Dickinson AM, Harrold JL, Cullup H. Haematopoietic stem cell transplantation: can our genes predict clinical outcome? Expert Rev Mol Med 2007; 9(29): 1-19.
28. Amiel J. Study of the leukocyte phenotypes in Hodgkin’s disease. ed. T.P.e.H. testing. 1967; Copenhagen: Munksgaard. 3.
29. Bozzacco L, et al. Strategy for Identifying Dendritic Cell-Processed CD4(+) T Cell Epitopes from the HIV Gag p24 Protein. PLoS One; 7(7): e41897.
30. Takenaka M, et al. Antibodies to MHC Class II Molecules Induce Autoimmunity: Critical Role for Macrophages in the Immunopathogenesis of Obliterative Airway Disease. PLoS One; 7(8): e42370.
31. Meresse B, Malamut G, Cerf-Bensussan N. Celiac disease: an immunological jigsaw. Immunity 2012; 36(6): 907-19.
32. Hasham A, Tomer Y. Genetic and epigenetic mechanisms in thyroid autoimmunity. Immunol Res 2012 Mar 29. (Epub ahead of print).
33. Karsh J, et al. Histocompatibility antigen combinations in rheumatoid arthritis. Clin Exp Rheumatol 1983; 1(1): 11-5.
34. Cohen JH, et al. HLA-DR antigens and the antibody response against Epstein-Barr virus. Tissue Antigens 1984; 23(3): 156-62.
35. Lundstrom E, et al. HLA-DRB1*04/*13 alleles are associated with vascular disease and antiphospholipid antibodies in systemic lupus erythematosus. Ann Rheum Dis. 2012 Aug 14. (Epub ahead of print).
36. Chinoy H, et al. Interaction of HLA-DRB1*03 and smoking for the development of anti-Jo-1 antibodies in adult idiopathic inflammatory myopathies: a European-wide case study. Ann Rheum Dis; 71(6): 961-5.
37. Novota P, et al. Diabetes mellitus in adults: association of HLA DRB1 and DQB1 diabetes risk alleles with GADab presence and C-peptide secretion. Immunol Lett 2004; 95(2): 229-32.
38. Kurppa K, et al. Utility of the new ESPGHAN criteria for the diagnosis of celiac disease in at-risk groups. J Pediatr Gastroenterol Nutr; 54(3): 387-91.
39. Kumar V, Wijmenga C. Celiac disease: update from the 14th International Celiac Disease Symposium 2011. Expert Rev Gastroenterol Hepatol; 5(6): 685-7.
40. Papadopoulos GK, Wijmenga C, Koning F. Interplay between genetics and the environment in the development of celiac disease: perspectives for a healthy life. J Clin Invest 2001; 108(9): 1261-6.
41. Westerberg DP, et al. New strategies for diagnosis and management of celiac disease. J Am Osteopath Assoc 2006; 106(3): 145-51.
42. Price P, et al. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol Rev 1999; 167: 257-74.